Medline Inc. Class A Common Stock vs Tempus AI — how do they compare? Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B), while Tempus AI trades at $69.87 (market cap $12.77B). The key difference: Medline Inc. Class A Common Stock is far larger — about 2.4× Tempus AI's market cap, and Tempus AI is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Tempus AI for 22 Days on average.
| MDLN | TEM | |
|---|---|---|
Market Cap | $31.10B | $12.77B |
Volume | 4,471,639 | 8,980,490 |
Sector | Health | Broad Market / Factor |
52-Week High | $49.99 | $99.28 |
52-Week Low | $31.64 | $41.55 |
Typical Hold Time | 0 Days | 22 Days |
Enterprise Value | $41.07B | $13.40B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →